She notes that "when people [generally] lose even a small amount of weight and improve their metabolic health, their risk of depression and anxiety goes down." This pattern existed before what she calls the "Ozempic revolution." In 2024, following an uptick in reports of suicidal thoughts and behaviors associated with GLP-1 use, the U.S
Remember that peptide research is an evolving field, and what we know about GLP3 safety continues to expand
When your dopamine system is working properly, it can help you enjoy things in moderation
In Phase III data , the highest retatrutide dose led to an average weight loss of 70.3 pounds, or 28.3% of body weight, over 80 weeks
Hou J, Wang B, Li J, Liu W